Background
- KRAS is the most frequently mutated oncogene in human cancer, including colorectal cancer.
- Adagrasib was recently approved by the US Food and Drug Administration for advanced non-small cell lung cancer.
- Adagrasib is a highly targeted, orally acting inhibitor of the mutant KRAS G12C protein ( KRAS G12C refers to a...